TCM
ABBV icon

Thoma Capital Management’s AbbVie ABBV Stock Holding History

Thoma Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Buy
1,703
+4
+0.2% +$861 0.23% 41
2026
Q1 		$370K Buy
1,699
+203
+14% +$45K 0.22% 45
2025
Q4 		$342K Sell
1,496
-28
-2% -$6.38K 0.2% 50
2025
Q3 		$353K Sell
1,524
-233
-13% -$47.4K 0.2% 50
2025
Q2 		$326K Sell
1,757
-225
-11% -$41.8K 0.21% 51
2025
Q1 		$415K Sell
1,982
-1,120
-36% -$218K 0.29% 48
2024
Q4 		$551K Buy
+3,102
New +$570K 0.38% 46

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Thoma Capital Management's ABBV Position: Q2 2026 in Review

Thoma Capital Management increased its AbbVie (ABBV) stake by 0.24% in Q2 2026, buying an estimated $861 and bringing the position to 1,703 shares worth $429K. The position accounts for 0.23% of the portfolio, ranked #41.

Thoma Capital Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $551K in Q4 2024. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Thoma Capital Management held 1,703 shares of AbbVie worth $429K as of Q2 2026.
  • Thoma Capital Management bought 4 AbbVie shares in Q2 2026, an estimated $861.
  • AbbVie made up 0.23% of Thoma Capital Management's portfolio in Q2 2026, its #41 holding.
  • Thoma Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Thoma Capital Management's AbbVie position peaked at $551K in Q4 2024.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Thoma Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.